Dark Forest Capital Management LP Protagonist Therapeutics, Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$24.66 - $34.8 $1.5 Million - $2.12 Million
60,962 New
60,962 $2.11 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $11.71 $8,308 - $12,377
1,057 Added 201.33%
1,582 $13,000
Q2 2022

Aug 15, 2022
BUY
$7.06 - $25.52 $3,706 - $13,398
525 New
525 $4,000

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.92B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email